Lei Xu

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 21

Top Venues

Chemical biology & drug design

Molecules (Basel, Switzerland)

RSC advances

Journal of molecular modeling

Jiangsu University of Technology

Soochow University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Jiangsu University of Technology Jan 01 2016

China

Associate professor :: Institute of Bioinformatics and Medical Engineering

Education History

Soochow University Sep 01 2010 - Dec 30 2013

China

PHD

Publications

Chun Zhang, Liangxu Xie, Xiaohua Lu, Rongzhi Mao, Lei Xu, Xiaojun Xu
Developing an Improved Cycle Architecture for AI-Based Generation of New Structures Aimed at Drug Discovery. Molecules (Basel, Switzerland) 29 (7) (2024)
Baiyi Li, Yunsong Wang, Zuode Yin, Lei Xu, Liangxu Xie, Xiaojun Xu
Decision tree-based identification of important molecular fragments for protein-ligand binding. Chemical biology & drug design 103 (1) (2024)
Chun Zhang, Liangxu Xie, Xiaohua Lu, Rongzhi Mao, Lei Xu, Xiaojun Xu
Developing an Improved Cycle Architecture for AI-Based Generation of New Structures Aimed at Drug Discovery. Molecules (Basel, Switzerland) 29 (7) (2024)
Baiyi Li, Yunsong Wang, Zuode Yin, Lei Xu, Liangxu Xie, Xiaojun Xu
Decision tree-based identification of important molecular fragments for protein-ligand binding. Chemical biology & drug design 103 (1) (2024)
Chun Zhang, Liangxu Xie, Xiaohua Lu, Rongzhi Mao, Lei Xu, Xiaojun Xu
Developing an Improved Cycle Architecture for AI-Based Generation of New Structures Aimed at Drug Discovery. Molecules (Basel, Switzerland) 29 (7) (2024)
Tianhao Wang, Jian-Bo Tong, Xing Zhang, Hao Luo, Lei Xu, Zhe Wang
In silico screening and computational evaluation of novel promising USP14 inhibitors targeting the palm-thumb pocket. Physical chemistry chemical physics : PCCP (2023)
Chao Shen, Xujun Zhang, Chang-Yu Hsieh, Yafeng Deng, Dong Wang, Lei Xu, Jian Wu, Dan Li, Yu Kang, Ting-Jun Hou, Peichen Pan
A generalized protein-ligand scoring framework with balanced scoring, docking, ranking and screening powers. Chemical science 14 (30) (2023)
Chenpeng Yao, Zheyuan Shen, Liteng Shen, Kailibinuer Kadier, Jingyi Zhao, Yu Guo, Lei Xu, Ji Cao, Xiaowu Dong, Bo Yang
Identification of Potential JNK3 Inhibitors: A Combined Approach Using Molecular Docking and Deep Learning-Based Virtual Screening. Pharmaceuticals (Basel, Switzerland) 16 (10) (2023)
Ying Zhang, Liangxu Xie, Da-Wei Zhang, Xiaojun Xu, Lei Xu
Application of Machine Learning Methods to Predict the Air Half-Lives of Persistent Organic Pollutants. Molecules (Basel, Switzerland) 28 (22) (2023)
Lei Xu, Liangxu Xie, Dawei Zhang, Xiaojun Xu
Elucidation of Binding Features and Dissociation Pathways of Inhibitors and Modulators in SARS-CoV-2 Main Protease by Multiple Molecular Dynamics Simulations. Molecules (Basel, Switzerland) 27 (20) (2022)
Linkang Sun, Min Zhang, Liangxu Xie, Xiaojun Xu, Peng Xu, Lei Xu
Computational prediction of Lee retention indices of polycyclic aromatic hydrocarbons by using machine learning. Chemical biology & drug design (2022)
Linkang Sun, Min Zhang, Liangxu Xie, Qian Gao, Xiaojun Xu, Lei Xu
In silico prediction of boiling point, octanol-water partition coefficient, and retention time index of polycyclic aromatic hydrocarbons through machine learning. Chemical biology & drug design (2022)
Jingyu Zhu, Lei Jia, Yingmin Jiang, Qianqian Yu, Lei Xu, Yanfei Cai, Yun Chen, Huazhong Li, Huang Gang, Wenqing Liang, Jian Jin
Integrated molecular modeling techniques to reveal selective mechanisms of inhibitors to PI3Kδ with marketed Idelalisib. Chemical biology & drug design 97 (6) (2021)
Liangxu Xie, Lei Xu, Shan Chang, Xiaojun Xu, Li Meng
Multitask deep networks with grid featurization achieve improved scoring performance for protein-ligand binding. Chemical biology & drug design 96 (3) (2021)
Zhengfang Zhang, Quan Han, Xiongxing Mao, Jinhua Liu, Wei Wang, Dong Li, Feng Zhou, Yang Ke, Lei Xu, Liu Hu
Discovery of novel SecA inhibitors against "Candidatus Liberibacter asiaticus" through virtual screening and biological evaluation. Chemical biology & drug design 98 (3) (2021)
Li Yu, Yingmin Jiang, Lei Xu, Jian Jin, Zejun Pei, Jingyu Zhu
Theoretical study of myriocin-binding mechanism targeting serine palmitoyltransferase. Chemical biology & drug design (2021)
Jingyu Zhu, Kan Li, Lei Xu, Jian Jin
Insight into the selective mechanism of phosphoinositide 3-kinase γ with benzothiazole and thiazolopiperidine γ-specific inhibitors by in silico approaches. Chemical biology & drug design 93 (5) (2019)
Enguang Yu, Yueping Xu, Yanbo Shi, Qiuyan Yu, Jie Liu, Lei Xu
Discovery of novel natural compound inhibitors targeting estrogen receptor α by an integrated virtual screening strategy. Journal of molecular modeling 25 (9) (2019)
Jingyu Zhu, Ke Ke, Lei Xu, Jian Jin
Discovery of a novel phosphoinositide 3-kinase gamma (PI3Kγ) inhibitor against hematologic malignancies and theoretical studies on its PI3Kγ-specific binding mechanisms. RSC advances 9 (35) (2019)
Lei Xu, Dayu Li, Junjie Ding, Li Pan, Xiaoqin Ding
Insight into tetrodotoxin blockade and resistance mechanisms of Nav 1.2 sodium channel by theoretical approaches. Chemical biology & drug design 92 (2) (2018)
Xianfeng Huang, Peng Xu, Yijing Cao, Li Liu, Guoqiang Song, Lei Xu
Exploring the binding mechanisms of PDE5 with chromeno[2,3- c ]pyrrol-9(2 H )-one by theoretical approaches. RSC advances 8 (53) (2018)

Lei Xu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Lei Xu